View in EDS PDF Full Text

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.

Saved in:
Bibliographic Details
Title: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.
Authors: Nasrallah HA; University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, Cincinnati, OH, 45219, USA. henry.nasrallah@uc.edu., Weiden PJ; Alkermes, Inc., Waltham, MA, USA., Walling DP; CNS Network, LLC, Garden Grove, CA, USA., Du Y; Alkermes, Inc., Waltham, MA, USA., Yao B; Alkermes, Inc., Waltham, MA, USA., Yagoda S; Alkermes, Inc., Waltham, MA, USA., Claxton A; Alkermes, Inc., Waltham, MA, USA.
Source: BMC psychiatry [BMC Psychiatry] 2021 Oct 08; Vol. 21 (1), pp. 492. Date of Electronic Publication: 2021 Oct 08.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34625041
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nasrallah+HA%22">Nasrallah HA</searchLink>; University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, Cincinnati, OH, 45219, USA. henry.nasrallah@uc.edu.<br /><searchLink fieldCode="AU" term="%22Weiden+PJ%22">Weiden PJ</searchLink>; Alkermes, Inc., Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CNS Network, LLC, Garden Grove, CA, USA.<br /><searchLink fieldCode="AU" term="%22Du+Y%22">Du Y</searchLink>; Alkermes, Inc., Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yao+B%22">Yao B</searchLink>; Alkermes, Inc., Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yagoda+S%22">Yagoda S</searchLink>; Alkermes, Inc., Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Claxton+A%22">Claxton A</searchLink>; Alkermes, Inc., Waltham, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968559%22">BMC psychiatry</searchLink> [BMC Psychiatry] 2021 Oct 08; Vol. 21 (1), pp. 492. <i>Date of Electronic Publication: </i>2021 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968559 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-244X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221471244X%22">1471244X </searchLink><i>NLM ISO Abbreviation: </i>BMC Psychiatry <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34625041
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12888-021-03420-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 492
    Titles:
      – TitleFull: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nasrallah HA
      – PersonEntity:
          Name:
            NameFull: Weiden PJ
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Du Y
      – PersonEntity:
          Name:
            NameFull: Yao B
      – PersonEntity:
          Name:
            NameFull: Yagoda S
      – PersonEntity:
          Name:
            NameFull: Claxton A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 10
              Text: 2021 Oct 08
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1471-244X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC psychiatry
              Type: main
ResultId 1